BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11776803)

  • 1. [A clinical retrospective review of stage IB1 and IB2 cervical cancer].
    Shao S; Sun L; Sun L
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):66-8. PubMed ID: 11776803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?
    Finan MA; DeCesare S; Fiorica JV; Chambers R; Hoffman MS; Kline RC; Roberts WS; Cavanagh D
    Gynecol Oncol; 1996 Aug; 62(2):139-47. PubMed ID: 8751541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of survival and adverse events between women with stage IB1 and stage IB2 cervical cancer treated by laparoscopic radical vaginal hysterectomy.
    Hong JH; Choi JS; Lee JH; Son CE; Jeon SW; Bae JW; Eom JM
    Ann Surg Oncol; 2012 Feb; 19(2):605-11. PubMed ID: 21769469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
    Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.
    Yessaian A; Magistris A; Burger RA; Monk BJ
    Gynecol Oncol; 2004 Jul; 94(1):61-6. PubMed ID: 15262120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of early stage cervical cancer: an assessment of pre-operative factors.
    Buekers TE; Kao MS; Phillips NJ; Xynos FP
    Gynecol Oncol; 2007 Mar; 104(3):665-9. PubMed ID: 17112568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
    J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?
    Kamelle SA; Rutledge TL; Tillmanns TD; Gould NS; Cohn DE; Wright J; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Aug; 94(2):249-55. PubMed ID: 15297159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
    Lowe MP; Chamberlain DH; Kamelle SA; Johnson PR; Tillmanns TD
    Gynecol Oncol; 2009 May; 113(2):191-4. PubMed ID: 19249082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
    Diaz JP; Sonoda Y; Leitao MM; Zivanovic O; Brown CL; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2008 Nov; 111(2):255-60. PubMed ID: 18755500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wertheim-operation: 5-year survival of 501 consecutive patients with cervical cancer].
    Papp Z; Csapó Z; Mayer A; Hupuczi P
    Orv Hetil; 2006 Mar; 147(12):537-45. PubMed ID: 16696377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors after surgery and adjuvant radiotherapy in cervical cancers. A retrospective analysis of 298 patients after surgery and adjuvant radiotherapy].
    Hänsgen G; Richter K; Gerlach R; Kuhnt T; Dunst J
    Strahlenther Onkol; 2005 May; 181(5):285-92. PubMed ID: 15900424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
    Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
    Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
    Kobayashi Y; Ohara T; Wada Y; Okuda Y; Kondo H; Okuma Y; Suzuki N; Gomi H; Kiguchi K; Ishizuka B
    J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.